ストックスクリーナーアプリを入手
5.61
12.20%
0.61
アフターアワーズ：
5.54
-0.07
-1.25%
前日終値:
$5.00
開ける：
$5.06
24時間の取引高:
4.31M
Relative Volume:
4.97
時価総額：
$343.18M
収益：
$91.06M
当期純損益:
$-503.14M
株価収益率:
-0.5655
EPS:
-9.92
ネットキャッシュフロー:
$-424.74M
1週間 パフォーマンス:
+4.18%
1か月 パフォーマンス:
+14.26%
6か月 パフォーマンス:
-47.42%
1年 パフォーマンス:
-73.13%
1日の値動き範囲:
$4.95
$5.62
1週間の範囲:
$4.94
$5.62
52週間の値動き範囲:
$4.62
$28.26
Sage Therapeutics Inc Stock (SAGE) Company Profile
名前
Sage Therapeutics Inc
セクター
電話
617-299-8380
住所
55 CAMBRIDGE PARKWAY, CAMBRIDGE, MA
SAGE を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SAGE
Sage Therapeutics Inc
|
5.61 | 343.18M | 91.06M | -503.14M | -424.74M | -8.39 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 102.31B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
701.85 | 77.13B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
623.82 | 37.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
245.44 | 31.66B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
113.08 | 27.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Sage Therapeutics Inc Stock (SAGE) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-11-21 | アップグレード | RBC Capital Mkts | Underperform → Sector Perform |
| 2024-10-10 | 再開されました | Raymond James | Mkt Perform |
| 2024-10-04 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-07-30 | ダウングレード | TD Cowen | Buy → Hold |
| 2024-07-25 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2024-05-29 | 開始されました | Citigroup | Sell |
| 2024-05-29 | 開始されました | Robert W. Baird | Neutral |
| 2024-04-17 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2023-12-12 | 開始されました | Deutsche Bank | Hold |
| 2023-08-08 | ダウングレード | Canaccord Genuity | Buy → Hold |
| 2023-08-08 | ダウングレード | Goldman | Buy → Neutral |
| 2023-08-08 | ダウングレード | Needham | Buy → Hold |
| 2023-08-07 | ダウングレード | BofA Securities | Buy → Neutral |
| 2023-08-07 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2023-08-07 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-08-07 | ダウングレード | Stifel | Buy → Hold |
| 2023-08-07 | ダウングレード | Wedbush | Outperform → Neutral |
| 2023-07-27 | 開始されました | Scotiabank | Sector Outperform |
| 2023-03-13 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-01-03 | ダウングレード | Guggenheim | Buy → Neutral |
| 2022-11-01 | 開始されました | Loop Capital | Hold |
| 2022-03-31 | 開始されました | Berenberg | Hold |
| 2021-11-02 | アップグレード | Guggenheim | Neutral → Buy |
| 2021-10-19 | 再開されました | Morgan Stanley | Equal-Weight |
| 2021-10-07 | ダウングレード | Jefferies | Buy → Hold |
| 2021-09-23 | 開始されました | Needham | Buy |
| 2021-06-16 | ダウングレード | Citigroup | Buy → Neutral |
| 2021-04-07 | 開始されました | Piper Sandler | Overweight |
| 2021-02-26 | ダウングレード | Mizuho | Buy → Neutral |
| 2021-02-25 | 繰り返されました | H.C. Wainwright | Neutral |
| 2021-02-02 | 再開されました | Raymond James | Mkt Perform |
| 2021-01-22 | ダウングレード | BMO Capital Markets | Outperform → Market Perform |
| 2021-01-04 | アップグレード | Guggenheim | Neutral → Buy |
| 2021-01-04 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-12-04 | アップグレード | Mizuho | Neutral → Buy |
| 2020-12-01 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2020-11-16 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2020-11-06 | 繰り返されました | H.C. Wainwright | Neutral |
| 2020-09-11 | アップグレード | Wedbush | Neutral → Outperform |
| 2020-08-10 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2020-05-08 | ダウングレード | Wedbush | Outperform → Neutral |
| 2020-04-08 | ダウングレード | Guggenheim | Buy → Neutral |
| 2020-03-18 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-03-06 | 開始されました | Citigroup | Buy |
| 2020-02-28 | 繰り返されました | H.C. Wainwright | Neutral |
| 2020-02-06 | 開始されました | Mizuho | Neutral |
| 2019-12-06 | 繰り返されました | RBC Capital Mkts | Outperform |
| 2019-12-05 | 繰り返されました | Guggenheim | Buy |
| 2019-12-05 | ダウングレード | SunTrust | Buy → Hold |
| 2019-10-30 | 開始されました | H.C. Wainwright | Neutral |
| 2019-05-23 | 開始されました | Wedbush | Outperform |
| 2019-04-25 | 開始されました | Jefferies | Buy |
| 2018-12-14 | 開始されました | Wolfe Research | Outperform |
| 2018-10-11 | 開始されました | Oppenheimer | Outperform |
すべてを表示
Sage Therapeutics Inc (SAGE) 最新ニュース
Postpartum Depression Therapeutics Market Size in the 7MM was ~USD 260 Million in 2023, is expected to grow by 2034, and estimates DelveInsight - The Globe and Mail
SAGE Investors Have Opportunity to Lead Sage Therapeutics, Inc. Securities Fraud Lawsuit - The Eastern Progress Online
SAGE Investors Have Opportunity to Lead Sage Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm - The Eastern Progress Online
Sage Therapeutics Inc Sued for Securities Law ViolationsContact the DJS Law Group to Discuss Your RightsSAGE - The Eastern Progress Online
Brokerages Set Sage Therapeutics, Inc. (NASDAQ:SAGE) Price Target at $11.53 - MarketBeat
Sage Therapeutics price target lowered to $6 from $10 at Stifel - Yahoo Finance
Where Sage Therapeutics Stands With Analysts - Benzinga
Stifel Nicolaus Has Lowered Expectations for Sage Therapeutics (NASDAQ:SAGE) Stock Price - MarketBeat
Sage Therapeutics' SWOT analysis: navigating challenges in CNS drug stock - Investing.com
Sage Therapeutics' SWOT analysis: navigating challenges in CNS drug stock By Investing.com - Investing.com UK
SAGE SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sage Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - The Eastern Progress Online
Levi & Korsinsky Notifies Sage Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineSAGE - The Eastern Progress Online
Layoff Tracker: Bavarian, BenevolentAI, Chroma Medicine and Nvelop Therapeutics Cut Staff - BioSpace
Sage Therapeutics shares stay Neutral rated by Mizuho, target cut on discontinued pipeline - Investing.com UK
Sage Therapeutics, Inc. (NASDAQ:SAGE) Shares Sold by Fmr LLC - MarketBeat
Shareholders that lost money on Sage Therapeutics, Inc.(SAGE) should contact The Gross Law Firm about pending Class ActionSAGE - The Eastern Progress Online
Investors who lost money on Sage Therapeutics, Inc.(SAGE) should contact The Gross Law Firm about pending Class ActionSAGE - The Eastern Progress Online
Class Action Filed Against Sage Therapeutics, Inc. (SAGE) Seeking Recovery for InvestorsContact The Gross Law Firm - The Eastern Progress Online
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Sage Therapeutics, Inc.(SAGE) Shareholders - The Eastern Progress Online
Sage Therapeutics, Inc. (NASDAQ:SAGE) Shares Sold by Jacobs Levy Equity Management Inc. - MarketBeat
RTW Investments LP Buys 111,123 Shares of Sage Therapeutics, Inc. (NASDAQ:SAGE) - MarketBeat
RBC Capital Upgrades Sage Therapeutics (SAGE) - MSN
Deutsche Bank Initiates Coverage of Sage Therapeutics (SAGE) with Hold Recommendation - MSN
Sage Therapeutics, Inc. Announces Retirement of Jeffrey M. Jonas as Member of Board of Directors , Effective December 1, 2024 - Marketscreener.com
Sage Therapeutics, Inc. Announces Resignation of Jeffrey M. Jonas as Member of Board of Directors , Effective December 1, 2024 - Marketscreener.com
SAGE (Sage Therapeutics) Change In Inventory : $0.0 Mil (TTM As of Sep. 2024) - GuruFocus.com
SAGE (Sage Therapeutics) Cash Flow from Financing : $10.4 Mil (TTM As of Sep. 2024) - GuruFocus.com
Rx Rundown: Novartis, Sage Therapeutics, Eli Lilly and more - MM+M Online
Sage Therapeutics announces board member retirement By Investing.com - Investing.com Nigeria
Sage Therapeutics announces board member retirement - Investing.com India
Sage Therapeutics' SWOT analysis: stock faces hurdles amid CNS pipeline setbacks By Investing.com - Investing.com South Africa
Sage Therapeutics to Present at the Piper Sandler 36th Annual Healthcare Conference - BioSpace
Sage Therapeutics' SWOT analysis: stock faces hurdles amid CNS pipeline setbacks - Investing.com
Sage Therapeutics Inc (SAGE) 財務データ
収益
当期純利益
現金流量
EPS
Sage Therapeutics Inc (SAGE) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| IGUCHI KIMI | CFO & Treasurer |
Jan 02 '24 |
Option Exercise |
1.36 |
1,642 |
2,233 |
70,429 |
2.88%
2.65%
大文字化:
|
ボリューム (24 時間):